483
Malladi Drugs & Pharmaceuticals Ltd. Unit 1Malladi Drugs & Pharmaceuticals Ltd. Unit 1 – FDA 483, Nov 7, 2022
Record Details
An FDA inspection of Malladi Drugs & Pharmaceuticals Limited, Unit-1 in Ranipet, India, revealed four significant observations related to manufacturing practices. Deficiencies included unscientific sampling procedures, inadequate validation protocols for equipment, lack of verification for critical cell count operations, and poor facility maintenance with visible contamination in a critical area. These issues indicate a need for improved quality control and facility upkeep.
View Company Profile
ID · 817c3f32-1c79-4a84-a529-814f1e7c40fb
Other documents for Malladi Drugs & Pharmaceuticals Ltd. Unit 1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.